Drug · DIN 02559358
XIPERE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 14, 2025.
- Drug Identification Number (DIN)
- 02559358
- Company (DIN owner)
- Bausch & Lomb Inc.Rochester, New York, United States
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Suprachoroidal
- Therapeutic class (ATC)
- Triamcinolone S01BA05
- Class
- Human
- Record last updated
- August 11, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRIAMCINOLONE ACETONIDE | 40 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 14, 2025: NOC 35661New Drug Submission (NDS)